

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63871028 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.63871028 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32941416 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.32941416 |
| 5 | * aromatic amino acid family catabolic process (GO:0009074) | 6.88871780 |
| 6 | * tryptophan catabolic process (GO:0006569) | 6.16562161 |
| 7 | * indole-containing compound catabolic process (GO:0042436) | 6.16562161 |
| 8 | * indolalkylamine catabolic process (GO:0046218) | 6.16562161 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05369163 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.96465309 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.90574909 |
| 12 | * kynurenine metabolic process (GO:0070189) | 5.82735290 |
| 13 | * tryptophan metabolic process (GO:0006568) | 5.81567287 |
| 14 | urea cycle (GO:0000050) | 5.66595772 |
| 15 | urea metabolic process (GO:0019627) | 5.66595772 |
| 16 | cysteine metabolic process (GO:0006534) | 5.57450141 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 5.49558985 |
| 18 | behavioral response to nicotine (GO:0035095) | 5.47160931 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.45135737 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.41061385 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.39298605 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.38475937 |
| 23 | protein carboxylation (GO:0018214) | 5.22015291 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.22015291 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.21921439 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.18055724 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.11651345 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.06263186 |
| 29 | homocysteine metabolic process (GO:0050667) | 5.06066472 |
| 30 | bile acid metabolic process (GO:0008206) | 5.05984888 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.03606172 |
| 32 | * aromatic amino acid family metabolic process (GO:0009072) | 5.00770084 |
| 33 | lysine catabolic process (GO:0006554) | 4.96819853 |
| 34 | lysine metabolic process (GO:0006553) | 4.96819853 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.87439000 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.85104155 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.75953144 |
| 38 | * alpha-amino acid catabolic process (GO:1901606) | 4.74546116 |
| 39 | regulation of complement activation (GO:0030449) | 4.74289472 |
| 40 | glycine metabolic process (GO:0006544) | 4.67528389 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.64041811 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.61955642 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55791931 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.55791931 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.55791931 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.54325858 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.54325858 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.48792140 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 4.47449853 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.46103191 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.44444095 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.44444095 |
| 53 | phospholipid efflux (GO:0033700) | 4.41470286 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.38449056 |
| 55 | * cellular amino acid catabolic process (GO:0009063) | 4.37843280 |
| 56 | cellular glucuronidation (GO:0052695) | 4.31272484 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.31216590 |
| 58 | imidazole-containing compound metabolic process (GO:0052803) | 4.30312352 |
| 59 | * indolalkylamine metabolic process (GO:0006586) | 4.27699814 |
| 60 | drug catabolic process (GO:0042737) | 4.27070077 |
| 61 | serine family amino acid biosynthetic process (GO:0009070) | 4.24862701 |
| 62 | glutamate metabolic process (GO:0006536) | 4.23632532 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.20319640 |
| 64 | * cellular biogenic amine catabolic process (GO:0042402) | 4.15802521 |
| 65 | * amine catabolic process (GO:0009310) | 4.15802521 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 4.14286909 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.10824151 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 4.10824151 |
| 69 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.10824151 |
| 70 | ethanol oxidation (GO:0006069) | 4.09148144 |
| 71 | * benzene-containing compound metabolic process (GO:0042537) | 4.07534094 |
| 72 | arginine metabolic process (GO:0006525) | 4.06571640 |
| 73 | cholesterol efflux (GO:0033344) | 4.03256118 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00956283 |
| 75 | aldehyde catabolic process (GO:0046185) | 4.00884989 |
| 76 | DNA deamination (GO:0045006) | 4.00509831 |
| 77 | sulfation (GO:0051923) | 3.91499822 |
| 78 | urate metabolic process (GO:0046415) | 3.90671925 |
| 79 | protein complex biogenesis (GO:0070271) | 3.90601075 |
| 80 | fibrinolysis (GO:0042730) | 3.87611078 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.86961016 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.86250005 |
| 83 | ketone body metabolic process (GO:1902224) | 3.86059580 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85421930 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.85116747 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.85116747 |
| 87 | * carboxylic acid catabolic process (GO:0046395) | 3.84331602 |
| 88 | * organic acid catabolic process (GO:0016054) | 3.84331602 |
| 89 | exogenous drug catabolic process (GO:0042738) | 3.78598116 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78159324 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 3.77554131 |
| 92 | drug transmembrane transport (GO:0006855) | 3.74731751 |
| 93 | cofactor catabolic process (GO:0051187) | 3.73514871 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.70212581 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.68501655 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68359910 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.68333575 |
| 98 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.67970672 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.67007380 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64512568 |
| 101 | complement activation (GO:0006956) | 3.62999531 |
| 102 | sterol homeostasis (GO:0055092) | 3.62887482 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62704854 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62082113 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62082113 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.59895706 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.58891410 |
| 108 | protein activation cascade (GO:0072376) | 3.57938307 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.56568566 |
| 110 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.56415627 |
| 111 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.54718371 |
| 112 | ATP synthesis coupled proton transport (GO:0015986) | 3.54718371 |
| 113 | L-fucose catabolic process (GO:0042355) | 3.49973849 |
| 114 | fucose catabolic process (GO:0019317) | 3.49973849 |
| 115 | L-fucose metabolic process (GO:0042354) | 3.49973849 |
| 116 | gamma-aminobutyric acid transport (GO:0015812) | 3.42287163 |
| 117 | nephron epithelium morphogenesis (GO:0072088) | 3.30148181 |
| 118 | nephron tubule morphogenesis (GO:0072078) | 3.30148181 |
| 119 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.29693768 |
| 120 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.29693768 |
| 121 | oxidative demethylation (GO:0070989) | 3.28729852 |
| 122 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.17779958 |
| 123 | mannosylation (GO:0097502) | 3.17204498 |
| 124 | intestinal cholesterol absorption (GO:0030299) | 3.12094994 |
| 125 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.10481877 |
| 126 | primary amino compound metabolic process (GO:1901160) | 3.09328265 |
| 127 | S-adenosylmethionine metabolic process (GO:0046500) | 2.96179630 |
| 128 | cellular response to ATP (GO:0071318) | 2.95610887 |
| 129 | maturation of 5.8S rRNA (GO:0000460) | 2.95495220 |
| 130 | amino acid salvage (GO:0043102) | 2.95451826 |
| 131 | L-methionine salvage (GO:0071267) | 2.95451826 |
| 132 | L-methionine biosynthetic process (GO:0071265) | 2.95451826 |
| 133 | GPI anchor metabolic process (GO:0006505) | 2.88673472 |
| 134 | flavonoid metabolic process (GO:0009812) | 2.86016186 |
| 135 | protein polyglutamylation (GO:0018095) | 2.84321919 |
| 136 | respiratory chain complex IV assembly (GO:0008535) | 2.83206285 |
| 137 | electron transport chain (GO:0022900) | 2.78852392 |
| 138 | positive regulation of fatty acid transport (GO:2000193) | 2.78824233 |
| 139 | respiratory electron transport chain (GO:0022904) | 2.74792442 |
| 140 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72381713 |
| 141 | negative regulation of telomere maintenance (GO:0032205) | 2.71642860 |
| 142 | cytochrome complex assembly (GO:0017004) | 2.65271263 |
| 143 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.64395769 |
| 144 | protein-cofactor linkage (GO:0018065) | 2.62281626 |
| 145 | peptidyl-glutamic acid modification (GO:0018200) | 2.61622698 |
| 146 | serotonin metabolic process (GO:0042428) | 2.61366113 |
| 147 | pseudouridine synthesis (GO:0001522) | 2.58805464 |
| 148 | vitamin biosynthetic process (GO:0009110) | 2.57209039 |
| 149 | regulation of glucokinase activity (GO:0033131) | 2.56424079 |
| 150 | regulation of hexokinase activity (GO:1903299) | 2.56424079 |
| 151 | * indole-containing compound metabolic process (GO:0042430) | 2.52871572 |
| 152 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.52210028 |
| 153 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.52210028 |
| 154 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.49193911 |
| 155 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.47202776 |
| 156 | positive regulation of icosanoid secretion (GO:0032305) | 2.47040660 |
| 157 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.45935942 |
| 158 | detection of light stimulus involved in visual perception (GO:0050908) | 2.45935942 |
| 159 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.44232174 |
| 160 | regulation of gene silencing by RNA (GO:0060966) | 2.42783937 |
| 161 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.42783937 |
| 162 | regulation of gene silencing by miRNA (GO:0060964) | 2.42783937 |
| 163 | transepithelial transport (GO:0070633) | 2.42691514 |
| 164 | dopamine transport (GO:0015872) | 2.42237652 |
| 165 | cellular anion homeostasis (GO:0030002) | 2.39815758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34899293 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22840237 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.00337955 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39272365 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19247189 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18100443 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84587854 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.13794160 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.11043816 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89065760 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.18287170 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.97416546 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.92570729 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68895949 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.50651682 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.49480517 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.22967729 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21259783 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.14156021 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.12761049 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11078396 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11013231 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10887615 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09970370 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09639057 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.08380818 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02676640 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8065943 |
| 29 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.97193383 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.89884678 |
| 31 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.88581940 |
| 32 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.87163458 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.85448713 |
| 34 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76274742 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73908343 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69066577 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68118546 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64664321 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60571412 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59482429 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54980778 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49667089 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.49474461 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48842914 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46634466 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46402260 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46396688 |
| 48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45932763 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44252291 |
| 50 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42724862 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42701192 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41625297 |
| 53 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.41456313 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41320750 |
| 55 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.40763285 |
| 56 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.40763285 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40548690 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39623980 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30544278 |
| 60 | NCOR_22424771_ChIP-Seq_293T_Human | 1.28704242 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28622026 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27433736 |
| 63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.25484441 |
| 64 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.25483675 |
| 65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24875130 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24461251 |
| 67 | ERA_21632823_ChIP-Seq_H3396_Human | 1.24096522 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23415813 |
| 69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23170871 |
| 70 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20313282 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20313282 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19988180 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19950592 |
| 74 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19593676 |
| 75 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19525509 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17182802 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16849658 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16239096 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14412297 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13890842 |
| 81 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.13650359 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12195208 |
| 83 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.11316336 |
| 84 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10083197 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08109577 |
| 86 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.05610289 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05594228 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04156582 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04127022 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04127022 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.02722865 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02188613 |
| 93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.98911474 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97768420 |
| 95 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97737183 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97163002 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97085669 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96962839 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95784997 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95344499 |
| 101 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94953829 |
| 102 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.94832031 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94523022 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92377402 |
| 105 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91240977 |
| 106 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90016125 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89904815 |
| 108 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89819659 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89553876 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89326800 |
| 111 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.89206297 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.89073386 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88978802 |
| 114 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88409570 |
| 115 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.88405709 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87712556 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86696536 |
| 118 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86103409 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83890997 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83208808 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82550995 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82124802 |
| 123 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81160225 |
| 124 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78998856 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77896762 |
| 126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77394258 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76699062 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76059361 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73519936 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71842427 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71595763 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70638978 |
| 133 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70575724 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66386753 |
| 135 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64512439 |
| 136 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.60110324 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60043548 |
| 138 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59805262 |
| 139 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55615358 |
| 140 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.54397762 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54174714 |
| 142 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53672304 |
| 143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.53570893 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52964940 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50416669 |
| 146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50024751 |
| 147 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49471088 |
| 148 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.48727514 |
| 149 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48004155 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47698146 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46903118 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46759399 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46507730 |
| 154 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46287136 |
| 155 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45701547 |
| 156 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45648742 |
| 157 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45538106 |
| 158 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.45426075 |
| 159 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.44919253 |
| 160 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44520679 |
| 161 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.44156363 |
| 162 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.43457280 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43349967 |
| 164 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.43271457 |
| 165 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.43249929 |
| 166 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.43249929 |
| 167 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.42451057 |
| 168 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41502449 |
| 169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.40490780 |
| 170 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.39751263 |
| 171 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.39251140 |
| 172 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.39012440 |
| 173 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.38775550 |
| 174 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38695814 |
| 175 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.38517912 |
| 176 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38381073 |
| 177 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.37976302 |
| 178 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.37674077 |
| 179 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37617505 |
| 180 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37118374 |
| 181 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.36632502 |
| 182 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35626067 |
| 183 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35180920 |
| 184 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.34923922 |
| 185 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34516965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15905301 |
| 2 | MP0005360_urolithiasis | 7.60901353 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27977327 |
| 4 | MP0005365_abnormal_bile_salt | 6.04378339 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13076917 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.17069020 |
| 7 | MP0003252_abnormal_bile_duct | 3.80545619 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.44605206 |
| 9 | MP0009840_abnormal_foam_cell | 3.27398741 |
| 10 | MP0005332_abnormal_amino_acid | 2.96318705 |
| 11 | MP0003195_calcinosis | 2.93231637 |
| 12 | MP0005083_abnormal_biliary_tract | 2.90627677 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.68431336 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.51836145 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.34867544 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.23898335 |
| 17 | MP0000609_abnormal_liver_physiology | 2.17702024 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.15410688 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.14321518 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.07469323 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.03546405 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.87472411 |
| 23 | MP0003868_abnormal_feces_composition | 1.81973927 |
| 24 | MP0002938_white_spotting | 1.80624338 |
| 25 | MP0001764_abnormal_homeostasis | 1.75766374 |
| 26 | MP0002160_abnormal_reproductive_system | 1.75096742 |
| 27 | MP0009046_muscle_twitch | 1.74249938 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.67820699 |
| 29 | MP0003122_maternal_imprinting | 1.65469761 |
| 30 | MP0005451_abnormal_body_composition | 1.65108492 |
| 31 | MP0001968_abnormal_touch/_nociception | 1.64628777 |
| 32 | MP0004142_abnormal_muscle_tone | 1.61905847 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59039765 |
| 34 | MP0003646_muscle_fatigue | 1.58067531 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.56464002 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.53299573 |
| 37 | MP0009697_abnormal_copulation | 1.52910309 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.47084675 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.46077110 |
| 40 | MP0004885_abnormal_endolymph | 1.43757554 |
| 41 | MP0003186_abnormal_redox_activity | 1.43312582 |
| 42 | MP0002102_abnormal_ear_morphology | 1.38762719 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.37689503 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.35792649 |
| 45 | MP0009745_abnormal_behavioral_response | 1.35056863 |
| 46 | MP0003136_yellow_coat_color | 1.34133448 |
| 47 | MP0002272_abnormal_nervous_system | 1.32150000 |
| 48 | MP0000631_abnormal_neuroendocrine_gland | 1.29800340 |
| 49 | MP0005389_reproductive_system_phenotype | 1.27106483 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.25981824 |
| 51 | MP0004133_heterotaxia | 1.25858493 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.24089086 |
| 53 | MP0000598_abnormal_liver_morphology | 1.22446159 |
| 54 | MP0002736_abnormal_nociception_after | 1.22297810 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.18879824 |
| 56 | MP0003011_delayed_dark_adaptation | 1.15889199 |
| 57 | MP0002163_abnormal_gland_morphology | 1.15676298 |
| 58 | MP0009764_decreased_sensitivity_to | 1.11707649 |
| 59 | MP0005410_abnormal_fertilization | 1.11687905 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.11356682 |
| 61 | MP0004742_abnormal_vestibular_system | 1.08771115 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 1.08013299 |
| 63 | MP0003878_abnormal_ear_physiology | 1.08013299 |
| 64 | MP0005253_abnormal_eye_physiology | 1.07768467 |
| 65 | MP0004147_increased_porphyrin_level | 1.07187655 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.06929203 |
| 67 | MP0005647_abnormal_sex_gland | 1.06737505 |
| 68 | MP0009763_increased_sensitivity_to | 1.04811690 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.04141688 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.02874110 |
| 71 | MP0008469_abnormal_protein_level | 1.00221067 |
| 72 | MP0002064_seizures | 0.99461599 |
| 73 | MP0002282_abnormal_trachea_morphology | 0.98839513 |
| 74 | MP0000566_synostosis | 0.98653757 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.97169550 |
| 76 | MP0003119_abnormal_digestive_system | 0.96799764 |
| 77 | MP0003121_genomic_imprinting | 0.95139904 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.95010428 |
| 79 | MP0001529_abnormal_vocalization | 0.94962149 |
| 80 | MP0000604_amyloidosis | 0.94544549 |
| 81 | MP0001486_abnormal_startle_reflex | 0.94542690 |
| 82 | MP0002234_abnormal_pharynx_morphology | 0.93309761 |
| 83 | MP0005195_abnormal_posterior_eye | 0.92762744 |
| 84 | MP0005408_hypopigmentation | 0.92685854 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.92500296 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.90224669 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.90220247 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.90182750 |
| 89 | MP0001905_abnormal_dopamine_level | 0.89587040 |
| 90 | MP0000049_abnormal_middle_ear | 0.89290347 |
| 91 | MP0002254_reproductive_system_inflammat | 0.89028756 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.87905304 |
| 93 | MP0003787_abnormal_imprinting | 0.87262718 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.86212773 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.83368508 |
| 96 | MP0001293_anophthalmia | 0.82395280 |
| 97 | MP0008058_abnormal_DNA_repair | 0.81594351 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.80390868 |
| 99 | MP0005670_abnormal_white_adipose | 0.79897378 |
| 100 | MP0001919_abnormal_reproductive_system | 0.78521338 |
| 101 | MP0001501_abnormal_sleep_pattern | 0.77902029 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.77640081 |
| 103 | MP0001756_abnormal_urination | 0.77502568 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.76019113 |
| 105 | MP0001970_abnormal_pain_threshold | 0.75555631 |
| 106 | MP0003698_abnormal_male_reproductive | 0.74624164 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.74463647 |
| 108 | MP0001661_extended_life_span | 0.74382830 |
| 109 | MP0003283_abnormal_digestive_organ | 0.74358416 |
| 110 | MP0008775_abnormal_heart_ventricle | 0.74037909 |
| 111 | MP0000026_abnormal_inner_ear | 0.73893774 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.73268238 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.72831713 |
| 114 | MP0002067_abnormal_sensory_capabilities | 0.72272708 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.71226881 |
| 116 | MP0001929_abnormal_gametogenesis | 0.71161907 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 0.71158375 |
| 118 | MP0000653_abnormal_sex_gland | 0.70327935 |
| 119 | MP0002971_abnormal_brown_adipose | 0.66868055 |
| 120 | MP0005334_abnormal_fat_pad | 0.66517759 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.66353088 |
| 122 | MP0003718_maternal_effect | 0.64453837 |
| 123 | MP0005266_abnormal_metabolism | 0.64214254 |
| 124 | MP0005535_abnormal_body_temperature | 0.63615904 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.61829545 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.61484302 |
| 127 | MP0004130_abnormal_muscle_cell | 0.60246553 |
| 128 | MP0003436_decreased_susceptibility_to | 0.59541189 |
| 129 | MP0005395_other_phenotype | 0.57686383 |
| 130 | MP0009053_abnormal_anal_canal | 0.56909457 |
| 131 | MP0003724_increased_susceptibility_to | 0.52043345 |
| 132 | MP0003690_abnormal_glial_cell | 0.50644157 |
| 133 | MP0005058_abnormal_lysosome_morphology | 0.49333922 |
| 134 | MP0002928_abnormal_bile_duct | 0.48709466 |
| 135 | MP0003329_amyloid_beta_deposits | 0.48638690 |
| 136 | MP0006082_CNS_inflammation | 0.48424803 |
| 137 | MP0005448_abnormal_energy_balance | 0.47268915 |
| 138 | MP0000639_abnormal_adrenal_gland | 0.46991474 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.46242914 |
| 140 | MP0008873_increased_physiological_sensi | 0.44665236 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.43079235 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.42663982 |
| 143 | MP0009672_abnormal_birth_weight | 0.41263629 |
| 144 | MP0001853_heart_inflammation | 0.39888687 |
| 145 | MP0008874_decreased_physiological_sensi | 0.39435828 |
| 146 | MP0003953_abnormal_hormone_level | 0.38856513 |
| 147 | MP0002822_catalepsy | 0.37582470 |
| 148 | MP0002168_other_aberrant_phenotype | 0.36615079 |
| 149 | MP0004043_abnormal_pH_regulation | 0.36366558 |
| 150 | MP0008872_abnormal_physiological_respon | 0.36268374 |
| 151 | MP0004381_abnormal_hair_follicle | 0.35482590 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.35335639 |
| 153 | MP0005166_decreased_susceptibility_to | 0.35076465 |
| 154 | MP0002132_abnormal_respiratory_system | 0.34263589 |
| 155 | MP0009115_abnormal_fat_cell | 0.33550042 |
| 156 | MP0009785_altered_susceptibility_to | 0.32813412 |
| 157 | MP0000230_abnormal_systemic_arterial | 0.31811284 |
| 158 | MP0003075_altered_response_to | 0.31302329 |
| 159 | MP0000249_abnormal_blood_vessel | 0.31160997 |
| 160 | MP0002837_dystrophic_cardiac_calcinosis | 0.29934772 |
| 161 | MP0002970_abnormal_white_adipose | 0.29109425 |
| 162 | MP0002135_abnormal_kidney_morphology | 0.28976416 |
| 163 | MP0001243_abnormal_dermal_layer | 0.28956588 |
| 164 | MP0001765_abnormal_ion_homeostasis | 0.28587023 |
| 165 | MP0000685_abnormal_immune_system | 0.28341598 |
| 166 | MP0004947_skin_inflammation | 0.27962675 |
| 167 | MP0001835_abnormal_antigen_presentation | 0.27837649 |
| 168 | MP0001881_abnormal_mammary_gland | 0.27409750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.33629315 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.99794723 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.99338930 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.59670873 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.19680606 |
| 6 | Xanthomatosis (HP:0000991) | 6.07107772 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.06597384 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.30707334 |
| 9 | Complement deficiency (HP:0004431) | 4.97040819 |
| 10 | Hyperglycinemia (HP:0002154) | 4.76966366 |
| 11 | Joint hemorrhage (HP:0005261) | 4.69239918 |
| 12 | Hyperammonemia (HP:0001987) | 4.67697999 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.53166954 |
| 14 | Hyperglycinuria (HP:0003108) | 4.43401004 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40226562 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.36999338 |
| 17 | Ketosis (HP:0001946) | 4.29011240 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.28853746 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.28853746 |
| 20 | Epidermoid cyst (HP:0200040) | 4.27979192 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27178706 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.26267219 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14774164 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11981088 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.00941408 |
| 26 | Fat malabsorption (HP:0002630) | 4.00930212 |
| 27 | Pancreatic cysts (HP:0001737) | 3.95975655 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.95540557 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.74133667 |
| 30 | Pancreatic fibrosis (HP:0100732) | 3.67711143 |
| 31 | Abnormality of complement system (HP:0005339) | 3.61438333 |
| 32 | True hermaphroditism (HP:0010459) | 3.59865321 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57145893 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55454126 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51200657 |
| 36 | Pendular nystagmus (HP:0012043) | 3.50732666 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.46818542 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38465917 |
| 39 | Congenital stationary night blindness (HP:0007642) | 3.37156418 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.33098680 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.32026090 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.31839778 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.15567114 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 3.11497017 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 3.11497017 |
| 46 | Ketoacidosis (HP:0001993) | 3.07280261 |
| 47 | Steatorrhea (HP:0002570) | 3.06767274 |
| 48 | Gout (HP:0001997) | 2.99287235 |
| 49 | Myocardial infarction (HP:0001658) | 2.98329441 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.97316351 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.97288963 |
| 52 | Nephronophthisis (HP:0000090) | 2.96336576 |
| 53 | Type II lissencephaly (HP:0007260) | 2.92990238 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.88678029 |
| 55 | Metabolic acidosis (HP:0001942) | 2.87368156 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.85287535 |
| 57 | Increased CSF lactate (HP:0002490) | 2.79020949 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.77975030 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 2.77414982 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.77110159 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77110159 |
| 62 | Lethargy (HP:0001254) | 2.76067546 |
| 63 | Abnormality of the renal cortex (HP:0011035) | 2.74734861 |
| 64 | Vascular calcification (HP:0004934) | 2.73603783 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.73164227 |
| 66 | Acute encephalopathy (HP:0006846) | 2.71822068 |
| 67 | Hepatocellular necrosis (HP:0001404) | 2.71601282 |
| 68 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.69252707 |
| 69 | Abnormality of alanine metabolism (HP:0010916) | 2.69252707 |
| 70 | Hyperalaninemia (HP:0003348) | 2.69252707 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69194659 |
| 72 | Spontaneous abortion (HP:0005268) | 2.67887971 |
| 73 | Hepatic necrosis (HP:0002605) | 2.66296066 |
| 74 | Skin nodule (HP:0200036) | 2.57519340 |
| 75 | Hypothermia (HP:0002045) | 2.56028039 |
| 76 | Cystic liver disease (HP:0006706) | 2.55231835 |
| 77 | Decreased central vision (HP:0007663) | 2.53733878 |
| 78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51617917 |
| 79 | Methylmalonic acidemia (HP:0002912) | 2.50855260 |
| 80 | Keratoconus (HP:0000563) | 2.49990857 |
| 81 | Increased corneal curvature (HP:0100692) | 2.49990857 |
| 82 | Irritability (HP:0000737) | 2.49072011 |
| 83 | Spastic diplegia (HP:0001264) | 2.44872838 |
| 84 | Mitral stenosis (HP:0001718) | 2.43683180 |
| 85 | Abnormality of the renal medulla (HP:0100957) | 2.43225841 |
| 86 | Acanthocytosis (HP:0001927) | 2.42148201 |
| 87 | Cardiovascular calcification (HP:0011915) | 2.40879525 |
| 88 | Congenital, generalized hypertrichosis (HP:0004540) | 2.40625671 |
| 89 | Glomerulonephritis (HP:0000099) | 2.40436404 |
| 90 | Cerebral edema (HP:0002181) | 2.39911664 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.37536671 |
| 92 | Neonatal onset (HP:0003623) | 2.37341917 |
| 93 | Sclerocornea (HP:0000647) | 2.37092097 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 2.33201747 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30682729 |
| 96 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30161443 |
| 97 | Progressive macrocephaly (HP:0004481) | 2.28890712 |
| 98 | Cholelithiasis (HP:0001081) | 2.28500532 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.28448423 |
| 100 | Malnutrition (HP:0004395) | 2.27090573 |
| 101 | Genetic anticipation (HP:0003743) | 2.23692076 |
| 102 | Abnormal number of erythroid precursors (HP:0012131) | 2.21480278 |
| 103 | Methylmalonic aciduria (HP:0012120) | 2.21063952 |
| 104 | Increased serum lactate (HP:0002151) | 2.20376578 |
| 105 | Furrowed tongue (HP:0000221) | 2.17891538 |
| 106 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17727417 |
| 107 | Bile duct proliferation (HP:0001408) | 2.16980045 |
| 108 | Abnormal biliary tract physiology (HP:0012439) | 2.16980045 |
| 109 | Vomiting (HP:0002013) | 2.16893642 |
| 110 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.16471136 |
| 111 | Pancreatitis (HP:0001733) | 2.15998228 |
| 112 | Alkalosis (HP:0001948) | 2.15364344 |
| 113 | Esophageal varix (HP:0002040) | 2.15000585 |
| 114 | Gingival bleeding (HP:0000225) | 2.13154645 |
| 115 | Attenuation of retinal blood vessels (HP:0007843) | 2.12908446 |
| 116 | Brushfield spots (HP:0001088) | 2.11055879 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.10715750 |
| 118 | Late onset (HP:0003584) | 2.10543607 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.09605135 |
| 120 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.08943204 |
| 121 | Enlarged kidneys (HP:0000105) | 2.08534471 |
| 122 | Menorrhagia (HP:0000132) | 2.07417574 |
| 123 | Poikilocytosis (HP:0004447) | 2.07190884 |
| 124 | Opisthotonus (HP:0002179) | 2.07079975 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.05300416 |
| 126 | Thrombophlebitis (HP:0004418) | 2.04390972 |
| 127 | Rickets (HP:0002748) | 2.03588647 |
| 128 | Male pseudohermaphroditism (HP:0000037) | 2.02953985 |
| 129 | Abnormal gallbladder physiology (HP:0012438) | 2.02020704 |
| 130 | Cholecystitis (HP:0001082) | 2.02020704 |
| 131 | Abnormality of proline metabolism (HP:0010907) | 2.01699148 |
| 132 | Hydroxyprolinuria (HP:0003080) | 2.01699148 |
| 133 | Hyperuricemia (HP:0002149) | 2.01001085 |
| 134 | Increased purine levels (HP:0004368) | 2.01001085 |
| 135 | Amyloidosis (HP:0011034) | 1.99638438 |
| 136 | Progressive cerebellar ataxia (HP:0002073) | 1.99094564 |
| 137 | Renal cortical cysts (HP:0000803) | 1.98939278 |
| 138 | Concave nail (HP:0001598) | 1.96949356 |
| 139 | Hypoplasia of the pons (HP:0012110) | 1.96710705 |
| 140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96277510 |
| 141 | Abnormality of the renal collecting system (HP:0004742) | 1.95396533 |
| 142 | Chorioretinal atrophy (HP:0000533) | 1.93499102 |
| 143 | Absent thumb (HP:0009777) | 1.93051382 |
| 144 | Medial flaring of the eyebrow (HP:0010747) | 1.92864899 |
| 145 | Glycosuria (HP:0003076) | 1.92833015 |
| 146 | Abnormality of urine glucose concentration (HP:0011016) | 1.92833015 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.92816897 |
| 148 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92740003 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.92389630 |
| 150 | Abnormality of the pons (HP:0007361) | 1.92355886 |
| 151 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.91979701 |
| 152 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.90913723 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.90856397 |
| 154 | Confusion (HP:0001289) | 1.90033353 |
| 155 | Abnormality of the gallbladder (HP:0005264) | 1.90004647 |
| 156 | Lactic acidosis (HP:0003128) | 1.89392387 |
| 157 | Meckel diverticulum (HP:0002245) | 1.89356965 |
| 158 | Optic disc pallor (HP:0000543) | 1.87697310 |
| 159 | Polydipsia (HP:0001959) | 1.87288446 |
| 160 | Abnormal drinking behavior (HP:0030082) | 1.87288446 |
| 161 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.87231159 |
| 162 | Abnormality of the ileum (HP:0001549) | 1.86881472 |
| 163 | Tubular atrophy (HP:0000092) | 1.86770600 |
| 164 | Elevated hepatic transaminases (HP:0002910) | 1.85790824 |
| 165 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82711637 |
| 166 | Severe muscular hypotonia (HP:0006829) | 1.82558084 |
| 167 | Birth length less than 3rd percentile (HP:0003561) | 1.82511490 |
| 168 | Inability to walk (HP:0002540) | 1.82375125 |
| 169 | Chronic hepatic failure (HP:0100626) | 1.82286764 |
| 170 | Lissencephaly (HP:0001339) | 1.81119651 |
| 171 | Abnormality of the nasal septum (HP:0000419) | 1.80934037 |
| 172 | Hypophosphatemic rickets (HP:0004912) | 1.80759071 |
| 173 | Congenital hepatic fibrosis (HP:0002612) | 1.76418268 |
| 174 | Patellar aplasia (HP:0006443) | 1.73471062 |
| 175 | Cerebellar dysplasia (HP:0007033) | 1.73022110 |
| 176 | Gaze-evoked nystagmus (HP:0000640) | 1.70726293 |
| 177 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.70356977 |
| 178 | Duplicated collecting system (HP:0000081) | 1.67866126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.15169197 |
| 2 | FGFR4 | 4.85794505 |
| 3 | SIK1 | 4.16289914 |
| 4 | ERN1 | 3.87788387 |
| 5 | ZAK | 3.70133038 |
| 6 | ADRBK2 | 3.41177855 |
| 7 | TLK1 | 3.27943096 |
| 8 | WNK4 | 3.25092201 |
| 9 | BMPR1B | 3.21389272 |
| 10 | TAOK3 | 2.98884739 |
| 11 | INSRR | 2.71236623 |
| 12 | MAP4K2 | 2.65046994 |
| 13 | ERBB4 | 2.38451456 |
| 14 | VRK2 | 2.37657188 |
| 15 | TYK2 | 2.28933880 |
| 16 | PKN2 | 2.14803994 |
| 17 | FLT3 | 1.96192701 |
| 18 | ACVR1B | 1.95566153 |
| 19 | MAPK11 | 1.92362841 |
| 20 | MST1R | 1.85724472 |
| 21 | VRK1 | 1.78262239 |
| 22 | TRIB3 | 1.75343500 |
| 23 | MAP2K4 | 1.74972321 |
| 24 | NEK9 | 1.64955636 |
| 25 | MAP3K14 | 1.63482650 |
| 26 | PIK3CG | 1.57538671 |
| 27 | TBK1 | 1.57024925 |
| 28 | MAPK13 | 1.56201796 |
| 29 | STK39 | 1.48524549 |
| 30 | OXSR1 | 1.48237036 |
| 31 | LATS1 | 1.47091929 |
| 32 | MAPKAPK3 | 1.44231223 |
| 33 | PTK6 | 1.35559499 |
| 34 | KDR | 1.34949411 |
| 35 | ABL2 | 1.34359798 |
| 36 | JAK1 | 1.32999277 |
| 37 | STK38L | 1.32323104 |
| 38 | MAPKAPK5 | 1.32294442 |
| 39 | IRAK3 | 1.29008678 |
| 40 | PIK3CA | 1.28281387 |
| 41 | PINK1 | 1.24831358 |
| 42 | MAP2K3 | 1.24425348 |
| 43 | JAK2 | 1.23608695 |
| 44 | GRK6 | 1.22997214 |
| 45 | MAP4K1 | 1.19253077 |
| 46 | IKBKE | 1.19238973 |
| 47 | MAP3K4 | 1.13382983 |
| 48 | MAP3K7 | 1.10918553 |
| 49 | PRKAA2 | 1.10595826 |
| 50 | PRKCG | 1.10315092 |
| 51 | DYRK2 | 1.08265092 |
| 52 | NME1 | 1.07851645 |
| 53 | FRK | 1.00839886 |
| 54 | DAPK2 | 0.99683622 |
| 55 | ADRBK1 | 0.96066612 |
| 56 | MAP3K3 | 0.94981582 |
| 57 | MAP3K10 | 0.90965041 |
| 58 | MAPK4 | 0.90476867 |
| 59 | RPS6KA5 | 0.90456382 |
| 60 | TXK | 0.89801043 |
| 61 | CASK | 0.89308703 |
| 62 | MKNK2 | 0.83330379 |
| 63 | NTRK3 | 0.83064238 |
| 64 | CDK6 | 0.81189077 |
| 65 | CDC7 | 0.81017223 |
| 66 | TGFBR1 | 0.79999555 |
| 67 | PRKCZ | 0.79510166 |
| 68 | BRSK2 | 0.79491736 |
| 69 | CSF1R | 0.79384699 |
| 70 | CSK | 0.78747519 |
| 71 | MAP3K11 | 0.77477729 |
| 72 | ERBB2 | 0.77183259 |
| 73 | SGK3 | 0.77102806 |
| 74 | DYRK1B | 0.76733807 |
| 75 | FGFR2 | 0.75932232 |
| 76 | CDK8 | 0.74623905 |
| 77 | PRKAA1 | 0.74432224 |
| 78 | CSNK1G3 | 0.73182345 |
| 79 | MAP2K7 | 0.73145267 |
| 80 | PLK3 | 0.71743978 |
| 81 | WEE1 | 0.71335043 |
| 82 | MAP2K6 | 0.71148439 |
| 83 | TAF1 | 0.70030712 |
| 84 | CSNK1A1L | 0.69798774 |
| 85 | CAMKK2 | 0.68362346 |
| 86 | MAPK12 | 0.68218657 |
| 87 | PRKCI | 0.66654657 |
| 88 | PNCK | 0.66283870 |
| 89 | PRKACG | 0.66279447 |
| 90 | EPHB1 | 0.66240568 |
| 91 | MUSK | 0.65997116 |
| 92 | PIM2 | 0.65893503 |
| 93 | PHKG2 | 0.65292268 |
| 94 | PHKG1 | 0.65292268 |
| 95 | PLK4 | 0.65254689 |
| 96 | CDK4 | 0.65064945 |
| 97 | PAK3 | 0.65063330 |
| 98 | PLK2 | 0.64949051 |
| 99 | ATR | 0.63777485 |
| 100 | PRKCE | 0.63508264 |
| 101 | FGFR3 | 0.63170131 |
| 102 | TGFBR2 | 0.62654329 |
| 103 | PDK4 | 0.62051316 |
| 104 | PDK3 | 0.62051316 |
| 105 | EPHA3 | 0.60984647 |
| 106 | CHEK2 | 0.60927236 |
| 107 | TIE1 | 0.60924661 |
| 108 | NEK2 | 0.59735815 |
| 109 | GSK3A | 0.59570749 |
| 110 | EPHA4 | 0.58932974 |
| 111 | SGK2 | 0.58382032 |
| 112 | CSNK1G2 | 0.58160642 |
| 113 | TRIM28 | 0.56947322 |
| 114 | MAP3K13 | 0.56552880 |
| 115 | TAOK2 | 0.55443868 |
| 116 | ZAP70 | 0.55270239 |
| 117 | MAPK15 | 0.54077652 |
| 118 | PRKACA | 0.53417635 |
| 119 | IKBKB | 0.53331249 |
| 120 | CSNK1A1 | 0.52269692 |
| 121 | KIT | 0.51949531 |
| 122 | EIF2AK3 | 0.51474581 |
| 123 | PRKCQ | 0.51472958 |
| 124 | NTRK2 | 0.50726358 |
| 125 | MAP3K5 | 0.49792982 |
| 126 | SIK2 | 0.49748429 |
| 127 | CHUK | 0.49473963 |
| 128 | CAMK2G | 0.49169506 |
| 129 | NEK1 | 0.49021846 |
| 130 | GRK5 | 0.47823373 |
| 131 | PLK1 | 0.46973616 |
| 132 | MAPK7 | 0.46065543 |
| 133 | BUB1 | 0.45741048 |
| 134 | JAK3 | 0.45322363 |
| 135 | PDPK1 | 0.45238064 |
| 136 | CSNK1D | 0.43524589 |
| 137 | CSNK2A1 | 0.43256735 |
| 138 | AURKA | 0.42790525 |
| 139 | GRK7 | 0.42160683 |
| 140 | MKNK1 | 0.40942824 |
| 141 | STK3 | 0.39430296 |
| 142 | IGF1R | 0.39283640 |
| 143 | SRPK1 | 0.39264630 |
| 144 | NME2 | 0.39063649 |
| 145 | CSNK1G1 | 0.38885209 |
| 146 | CAMK1D | 0.38786947 |
| 147 | STK16 | 0.38719364 |
| 148 | GRK1 | 0.38570826 |
| 149 | DAPK1 | 0.37884206 |
| 150 | MST4 | 0.37499943 |
| 151 | ITK | 0.37289788 |
| 152 | MAP2K2 | 0.36379668 |
| 153 | AKT3 | 0.35641696 |
| 154 | CSNK1E | 0.35416347 |
| 155 | PTK2 | 0.35106913 |
| 156 | PRKCA | 0.34994895 |
| 157 | MET | 0.34977282 |
| 158 | SGK494 | 0.34824247 |
| 159 | SGK223 | 0.34824247 |
| 160 | CAMK2A | 0.34661840 |
| 161 | CSNK2A2 | 0.34295609 |
| 162 | BTK | 0.34212081 |
| 163 | PKN1 | 0.34169034 |
| 164 | WNK3 | 0.33558284 |
| 165 | PIM1 | 0.33348121 |
| 166 | PDK1 | 0.33343333 |
| 167 | PTK2B | 0.33241224 |
| 168 | MTOR | 0.32371793 |
| 169 | BLK | 0.30917834 |
| 170 | EIF2AK1 | 0.29568568 |
| 171 | NUAK1 | 0.27752357 |
| 172 | MAP2K1 | 0.27164071 |
| 173 | LYN | 0.27015930 |
| 174 | EGFR | 0.26266041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39347161 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44878641 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44440866 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28377018 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00234011 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.63236021 |
| 7 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61803652 |
| 8 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59994061 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59395046 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56983719 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48643357 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44162546 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39691614 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.35036635 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.29142845 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20281848 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.12354927 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12223159 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97093821 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93792336 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92933124 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91169508 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90207558 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90118175 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87993103 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80922228 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.79435628 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78692766 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77313726 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76276613 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.73912028 |
| 32 | RNA polymerase_Homo sapiens_hsa03020 | 1.72295125 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71267810 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70316208 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68062811 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65468238 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.65300213 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62216780 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58839071 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58653434 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.58382930 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48029000 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.46576371 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.43792377 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39669020 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38248141 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37163322 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34005438 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32999568 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28646114 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28244813 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24341105 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24171562 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.23548050 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22140557 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20744959 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18856901 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.17892686 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17556898 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17278397 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16665849 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.14904720 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12826023 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12044148 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08225623 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05006662 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03347875 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02067939 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01688902 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00296398 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97454545 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97015264 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95258898 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.94138820 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93637085 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.90614270 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90350068 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.90307269 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88991184 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87305506 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86669357 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.84797091 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72449845 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69033992 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66307471 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.66114648 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65193312 |
| 88 | DNA replication_Homo sapiens_hsa03030 | 0.61969801 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59063022 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.57973086 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52947766 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.52374339 |
| 93 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47834732 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.47522796 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.44502625 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41589387 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39485464 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.38554718 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.38477377 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36930510 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36678037 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34660727 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30008707 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.25967405 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24451753 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.21403337 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21079692 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20400835 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17085982 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17072452 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13978264 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.02944546 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02734666 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00063800 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2389051 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2298021 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2279971 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2256287 |
| 119 | Lysosome_Homo sapiens_hsa04142 | -0.2141938 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2137486 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1881905 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1821577 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1780093 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1768217 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1629956 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1583283 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.1433399 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1411770 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1372711 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1336518 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1332475 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1065510 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0592143 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0067491 |

